Acquires Bloc83 in CBD Raleigh in Joint Venture with the North Carolina Investment Authority$21.0M Total Investment (at HIW 10% Share)492,000 Square Feet, 97% Leased___________________________________ ...
DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment practices, persistent corneal edema emerging drugs, market share of ...
Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) in the first study of a cardiac myosin inhibitor (CMI) in adolescents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback